Avantra, MedTrust Online Ink MDx Partnership

Avantra will identify biomarkers of interest, and MedTrust will engage oncologists in online discussions that will validate the role of different panels in diagnosis, prognosis, and treatment efficacy.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.